Speaker Biography

Dedy Arisjulyanto

Dedy Arisjulyanto is one of the postgraduate students of Public Health Universitas Gadjah Mada, he has expertise in overcoming non communicable diseases with complementary therapy, this research was conducted directly in the community and analyzed it by quantitative way and various theoretical references, this research became a very good recommendation in overcoming hypertension problem in world



Purpose: Hypertension is one of the leading causes of mortality in Indonesia, there is a significantly increasing trend in annual hypertension prevalence in Indonesia. Hypertension is one of the most common diseases in NTB, the prevalence of hypertension measured based on blood pressure in NTB is 1,523,574 (32.4%), it is higher than the national rate (1,255,537 (26.7%) of 4,702,389 people). The highest prevalence of hypertension in Mataram City is in Cakranegara Primary Care, there are 724 people with hypertension in this primary care working area. The purpose of this study is to determine the average number of patient’s hypertension rate at Cakranegara Primary Care before and after given muscle relaxation techniques.

Method: This study uses "Quasi Experiment Design" with control group as comparison. The population in this study are 724 hypertension patients and 27 patients as sample based on inclusion and exclusion criteria.

Results: The results of this study indicates that the T-test calculation using Quasi Experiment Design shows the difference of average of hypertension rate before and after given progressive muscle relaxation technique. It is 10,306 mmHg in intervention group and 1,425 mmHg in control group. The p-value in the intervention group is 0.000 that is smaller than α = 0.05 and the p-value of control group is 0.431 that is greater than α = 0.05.

Conclusion: From this study, we can conclude that there is a difference of hypertension rate between intervention and control group. We hope this progressive muscle relaxation technique can be used as an appropriate alternative or complementing treatment to control Hypertension rate.